Clinical trial
Ceftobiprole in Hospital Acquired Pneumonia
NCT00210964 · Basilea Pharmaceutica, Industry · Completed
Key facts
| NCT number | NCT00210964 |
|---|---|
| Title | Ceftobiprole in Hospital Acquired Pneumonia |
| Official title | A Phase III Randomized Double-Blind Study Of Ceftobiprole Versus Linezolid Plus Ceftazidime In The Treatment Of Nosocomial Pneumonia |
| Lead sponsor | Basilea Pharmaceutica, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pneumonia |
| Intervention type | Drug |
| Interventions | ceftobiprole plus placebo, linezolid plus ceftazidime |
| Enrollment | 781 |
| Start date | Apr 1, 2005 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Sep 21, 2005 |
| Last update posted | Sep 3, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: